Effects of a long-acting LHRH agonist preparation on plasma gonadotropin and prolactin levels in castrated male rats and on the release of prolactin from ectopic pituitaries

Kara J. Sellers, M. Susan Smith, Francisco J. Rojas, Ricardo H. Asch, Andrew V Schally, Andrzej Bartke

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

We have examined the effects of a single subcutaneous injection of an LHRH agonist, d-Trp-6-LHRH, in biodegradable microcapsules of poly(dl-lactide-co-glycolide) on plasma gonadotropin and prolactin (PRL) levels in castrated and in castrated-hypophysectomized-pituitary grafted (CAST-APX-GRAFT) male rats. The results were compared to the effects of daily injections of the same LHRH agonist dissolved in saline. In castrated rats, there were no significant alterations in plasma LH or PRL levels during the 10 days following the injection of LHRH agonist microcapsules, while FSH levels were generally reduced. In castrated males given daily injections of 6 μg of LHRH agonist in saline, plasma LH levels were significantly reduced while plasma PRL levels were not changed. In CAST-APX-GRAFT rats, both d-Trp-6-LHRH microcapsules and daily LHRH agonist injections appeared to increase plasma PRL levels. The pattern of changes in PRL release in both groups was similar, with levels on day 6 being significantly higher than those measured on days 1, 3 and 10 after onset of treatment. As expected, LH and FSH levels in these animals were extremely low. Immunoreactive d-Trp-6-LHRH was consistently detectable in the plasma of CAST-APX-GRAFT animals after microcapsule administration, whereas in animals given daily injections of this agonist in saline, its plasma concentrations were often below the detectability limit of the employed assay. These findings suggest that the LHRH agonist, d-Trp-6-LHRH, is capable of causing a short term stimulation of PRL release from ectopic pituitaries. Elevation of plasma LH levels is apparently not required for this effect.

Original languageEnglish
Pages (from-to)219-228
Number of pages10
JournalRegulatory Peptides
Volume15
Issue number3
DOIs
StatePublished - Jan 1 1986
Externally publishedYes

Fingerprint

Gonadotropins
Gonadotropin-Releasing Hormone
Prolactin
Rats
Plasmas
Capsules
Injections
Animals
Polyglactin 910
Subcutaneous Injections
Assays

Keywords

  • biodegradable microcapsules
  • follicle-stimulating hormone
  • luteinizing hormone
  • rats

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Physiology
  • Neuroscience(all)

Cite this

Effects of a long-acting LHRH agonist preparation on plasma gonadotropin and prolactin levels in castrated male rats and on the release of prolactin from ectopic pituitaries. / Sellers, Kara J.; Susan Smith, M.; Rojas, Francisco J.; Asch, Ricardo H.; Schally, Andrew V; Bartke, Andrzej.

In: Regulatory Peptides, Vol. 15, No. 3, 01.01.1986, p. 219-228.

Research output: Contribution to journalArticle

@article{e6374076895a40f6be02261e91293ba5,
title = "Effects of a long-acting LHRH agonist preparation on plasma gonadotropin and prolactin levels in castrated male rats and on the release of prolactin from ectopic pituitaries",
abstract = "We have examined the effects of a single subcutaneous injection of an LHRH agonist, d-Trp-6-LHRH, in biodegradable microcapsules of poly(dl-lactide-co-glycolide) on plasma gonadotropin and prolactin (PRL) levels in castrated and in castrated-hypophysectomized-pituitary grafted (CAST-APX-GRAFT) male rats. The results were compared to the effects of daily injections of the same LHRH agonist dissolved in saline. In castrated rats, there were no significant alterations in plasma LH or PRL levels during the 10 days following the injection of LHRH agonist microcapsules, while FSH levels were generally reduced. In castrated males given daily injections of 6 μg of LHRH agonist in saline, plasma LH levels were significantly reduced while plasma PRL levels were not changed. In CAST-APX-GRAFT rats, both d-Trp-6-LHRH microcapsules and daily LHRH agonist injections appeared to increase plasma PRL levels. The pattern of changes in PRL release in both groups was similar, with levels on day 6 being significantly higher than those measured on days 1, 3 and 10 after onset of treatment. As expected, LH and FSH levels in these animals were extremely low. Immunoreactive d-Trp-6-LHRH was consistently detectable in the plasma of CAST-APX-GRAFT animals after microcapsule administration, whereas in animals given daily injections of this agonist in saline, its plasma concentrations were often below the detectability limit of the employed assay. These findings suggest that the LHRH agonist, d-Trp-6-LHRH, is capable of causing a short term stimulation of PRL release from ectopic pituitaries. Elevation of plasma LH levels is apparently not required for this effect.",
keywords = "biodegradable microcapsules, follicle-stimulating hormone, luteinizing hormone, rats",
author = "Sellers, {Kara J.} and {Susan Smith}, M. and Rojas, {Francisco J.} and Asch, {Ricardo H.} and Schally, {Andrew V} and Andrzej Bartke",
year = "1986",
month = "1",
day = "1",
doi = "10.1016/0167-0115(86)90063-7",
language = "English",
volume = "15",
pages = "219--228",
journal = "Regulatory Peptides",
issn = "0167-0115",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Effects of a long-acting LHRH agonist preparation on plasma gonadotropin and prolactin levels in castrated male rats and on the release of prolactin from ectopic pituitaries

AU - Sellers, Kara J.

AU - Susan Smith, M.

AU - Rojas, Francisco J.

AU - Asch, Ricardo H.

AU - Schally, Andrew V

AU - Bartke, Andrzej

PY - 1986/1/1

Y1 - 1986/1/1

N2 - We have examined the effects of a single subcutaneous injection of an LHRH agonist, d-Trp-6-LHRH, in biodegradable microcapsules of poly(dl-lactide-co-glycolide) on plasma gonadotropin and prolactin (PRL) levels in castrated and in castrated-hypophysectomized-pituitary grafted (CAST-APX-GRAFT) male rats. The results were compared to the effects of daily injections of the same LHRH agonist dissolved in saline. In castrated rats, there were no significant alterations in plasma LH or PRL levels during the 10 days following the injection of LHRH agonist microcapsules, while FSH levels were generally reduced. In castrated males given daily injections of 6 μg of LHRH agonist in saline, plasma LH levels were significantly reduced while plasma PRL levels were not changed. In CAST-APX-GRAFT rats, both d-Trp-6-LHRH microcapsules and daily LHRH agonist injections appeared to increase plasma PRL levels. The pattern of changes in PRL release in both groups was similar, with levels on day 6 being significantly higher than those measured on days 1, 3 and 10 after onset of treatment. As expected, LH and FSH levels in these animals were extremely low. Immunoreactive d-Trp-6-LHRH was consistently detectable in the plasma of CAST-APX-GRAFT animals after microcapsule administration, whereas in animals given daily injections of this agonist in saline, its plasma concentrations were often below the detectability limit of the employed assay. These findings suggest that the LHRH agonist, d-Trp-6-LHRH, is capable of causing a short term stimulation of PRL release from ectopic pituitaries. Elevation of plasma LH levels is apparently not required for this effect.

AB - We have examined the effects of a single subcutaneous injection of an LHRH agonist, d-Trp-6-LHRH, in biodegradable microcapsules of poly(dl-lactide-co-glycolide) on plasma gonadotropin and prolactin (PRL) levels in castrated and in castrated-hypophysectomized-pituitary grafted (CAST-APX-GRAFT) male rats. The results were compared to the effects of daily injections of the same LHRH agonist dissolved in saline. In castrated rats, there were no significant alterations in plasma LH or PRL levels during the 10 days following the injection of LHRH agonist microcapsules, while FSH levels were generally reduced. In castrated males given daily injections of 6 μg of LHRH agonist in saline, plasma LH levels were significantly reduced while plasma PRL levels were not changed. In CAST-APX-GRAFT rats, both d-Trp-6-LHRH microcapsules and daily LHRH agonist injections appeared to increase plasma PRL levels. The pattern of changes in PRL release in both groups was similar, with levels on day 6 being significantly higher than those measured on days 1, 3 and 10 after onset of treatment. As expected, LH and FSH levels in these animals were extremely low. Immunoreactive d-Trp-6-LHRH was consistently detectable in the plasma of CAST-APX-GRAFT animals after microcapsule administration, whereas in animals given daily injections of this agonist in saline, its plasma concentrations were often below the detectability limit of the employed assay. These findings suggest that the LHRH agonist, d-Trp-6-LHRH, is capable of causing a short term stimulation of PRL release from ectopic pituitaries. Elevation of plasma LH levels is apparently not required for this effect.

KW - biodegradable microcapsules

KW - follicle-stimulating hormone

KW - luteinizing hormone

KW - rats

UR - http://www.scopus.com/inward/record.url?scp=0022549945&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022549945&partnerID=8YFLogxK

U2 - 10.1016/0167-0115(86)90063-7

DO - 10.1016/0167-0115(86)90063-7

M3 - Article

VL - 15

SP - 219

EP - 228

JO - Regulatory Peptides

JF - Regulatory Peptides

SN - 0167-0115

IS - 3

ER -